QUANT BIOMARKERS COMPANY

quant-biomarkers-company-logo

Specialises in the quantitative assessment of Biomarkers of Human Longevity, the development of personalised biomarker panels of aging, and oncology, fields which target established Hallmarks of Aging. It also supports investment de-risking across various sectors, including R&D and clinical and health insurance. Quant Biomarkers is an AI and tech-powered platform that will further contribute to the creation of structured financial products and analytics linked to biological age. Its main goal ... is the synthesis and validation of a tangible, effective, and personalized assessment approach that supports interventions and Longevity Medicine therapeutic modalities. The company will also serve as an incubator, IP accelerator, and investment vehicle for the Longevity Biomarkers sector, acquiring the most prospective start-ups, teams, and R&D facilities in the industry for the development of Longevity Preventive Medicine and Precision Health products as well as financial and analytical services.

#People #Website #More

QUANT BIOMARKERS COMPANY

Social Links:

Industry:
Biotechnology Market Research

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.quant-biomarkers.com

Total Employee:
1+

Status:
Active


Current Employees Featured

ihor-kendiukhov_image

Ihor Kendiukhov
Ihor Kendiukhov Head of AI, ML and Tech Departments @ Quant Biomarkers Company
Head of AI, ML and Tech Departments

not_available_image

Andrey Savitskiy
Andrey Savitskiy Biotech Lifesciences Expert @ Quant Biomarkers Company
Biotech Lifesciences Expert

alexei-cresniov_image

Alexei Cresniov
Alexei Cresniov Director @ Quant Biomarkers Company
Director

anastasia-lit_image

Anastasia Lit
Anastasia Lit Business Development and Investor Relations @ Quant Biomarkers Company
Business Development and Investor Relations

emma-brodina_image

Emma Brodina
Emma Brodina Deputy Managing Partner @ Quant Biomarkers Company
Deputy Managing Partner

not_available_image

Dominic Atkins
Dominic Atkins Head Business Development Quant Biomarkers @ Quant Biomarkers Company
Head Business Development Quant Biomarkers

Official Site Inspections

http://www.quant-biomarkers.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Quant Biomarkers Company"

Quant Biomarkers Company - Crunchbase Company Profile

Quant Biomarkers is an AI and tech-powered platform that will further contribute to the creation of structured financial products and analytics linked to biological age. Its main goal is the โ€ฆSee details»

Quant Biomarkers - LinkedIn

Quant Biomarkers is a data-driven biomedical company focused on analysis and validation of longitudinal clinical data and personalised biomarkers assessment to support intervention decisions and ...See details»

Quant Biomarkers AG - Swiss Biotech

Quant Biomarkers aims to revolutionize cardio-renal and metabolic health with AI-driven solutions and novel biomarkers. We are at the forefront of precision medicine and our goal is to โ€ฆSee details»

Quant Biomarkers - PitchBook

When was Quant Biomarkers founded? Quant Biomarkers was founded in 2021. Who is the founder of Quant Biomarkers? Sanja Tomovska Ph.D, Samuel โ€ฆSee details»

Quant Biomarkers AG - Sip Baselarea

Quant Biomarkers AG. 30. October 2023. Sina Kohlbrenner. Our approach leverage innovations in biomarker technology and AI modelling to address the growing healthcare challenges โ€ฆSee details»

Quant Biomarkers AG Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Quant Biomarkers AG of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.See details»

Quant Biomarkers AG - startup.ch

Quant Biomarkers aims to revolutionize renal and cardiometabolic health with novel early biomarker test and AI-driven solution. Based in Switzerland, we address chronic kidney โ€ฆSee details»

Deep Knowledge Group Announces Launch of New Strategic โ€ฆ

About Quant Biomarkers Quant Biomarkers is a data-driven financial and biotechnology company specializing in quantitative assessment of human biomarkers; the development of biomarker โ€ฆSee details»

Team - Quant Biomarkers

Epigenetics and Single cell technology Associate Professor (Reader) Queen's University BelfastSee details»

About - Quant Biomarkers

Quant Biomarkers' primary mission is to advance new biomarker technologies for healthy lifespan and support interventions in longevity medicine "Our focus is on developing personalised biomarker panels for early detection of health decay โ€ฆSee details»

Partners | Quant Biomarkers

Since 2022 he is a member of the scientific advisory board of the Quant Biomarkers company. PXM - Precise x Med. ... The Hadassah Medical Organizationโ€™s (HMO) two Jerusalem โ€ฆSee details»

QuantBioMed

By seamlessly integrating AI, real-world data, and cutting-edge computational biology, we are transforming the landscape of biomarker discoveryโ€” accelerating the transition from discovery โ€ฆSee details»

Quant Biomarkers Overview | SignalHire Company Profile

Organization Website: quant-biomarkers.com : Social Links: Quant Biomarkers industries Biotech: Headquarters Location: Basel, CH Basel, CH : Quant Biomarkers Employees Size 1-10 โ€ฆSee details»

Deep Knowledge Group Announces Launch of New Strategic โ€ฆ

Dec 10, 2021 Deep Knowledge Ventures Swiss Sarl and Quant Biomarkers will also lead development of Longevity International Association and Swiss Longevity Valley, major non โ€ฆSee details»

Sanja Baumann-Tomovska - Sejelas

Feb 14, 2024 Dr. Sanja Baumann-Tomovska is the Founder of CEO of Quant Biomarkers and Country Chair of the VAB Swiss chapter, amongst other Board positions.. She has a vast โ€ฆSee details»

Quant Biomarkers Company Swiss profiles - FinalScout

Quant Biomarkers is a data-driven biomedical analytical company focused on the synthesis and validation of a tangible, effective, and personalised biomarkers assessment to support โ€ฆSee details»

Deep Knowledge Group Announces Launch of New Strategic โ€ฆ

Jan 22, 2024 The unified data-driven Biomarkers Platform specializes in the aggregation and synthesis of validated biomarker technologies for the development of sophisticated analytical โ€ฆSee details»

A bioinformatics-driven approach to identify biomarkers and

5 days ago A bioinformatics-driven approach to identify biomarkers and elucidate the pathogenesis of type 2 diabetes concurrent with pulmonary tuberculosisSee details»

Deep Knowledge Group Announces Launch of New Strategic โ€ฆ

Dec 10, 2021 Quant Biomarkers is an AI and tech-powered platform that will further contribute to the creation of structured financial products and analytics linked to biological age. Company โ€ฆSee details»

Use Cases | Quant Biomarkers

Insurances can be more accurate and more confidence in risk predictions by using scientifically proven our biomarkers . Disease Prevention. Based on validated biomarkers insurance โ€ฆSee details»